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Abstract
Cationic, triple-chain amphiphiles promote vesicle fusion more than structurally related double-chain or single-chain analogues. Two
types of vesicle fusion experiments were conducted, mixing of oppositely charged vesicles and acid-triggered self-fusion of vesicles
composed of cationic amphiphile and anionic cholesteryl hemisuccinate (CHEMS). Vesicle fusion was monitored by standard fluorescence
assays for intermembrane lipid mixing, aqueous contents mixing and leakage. Differential scanning calorimetry was used to show that triple-
chain amphiphiles lower the lamellar– inverse hexagonal (La–HII) phase transition temperature for dipalmitoleoylphosphatidylethanolamine.
The triple-chain amphiphiles may enhance vesicle fusion because they can stabilize the inversely curved membrane surfaces of the fusion
intermediates, however, other factors such as extended conformation, packing defects, chain motion, or surface dehydration may also
contribute. From the perspective of drug delivery, the results suggest that vesicles containing cationic, triple-chain amphiphiles (and cationic,
cone-shaped amphiphiles in general) may be effective as fusogenic delivery capsules.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The mechanism of bilayer membrane fusion [1–4], a
critical cellular process, is the subject of ongoing experi-
mental [5–11] and theoretical studies [12–14]. Although
major progress has been made over the past decade, there is
still only a moderate mechanistic understanding at the
molecular level. Much of the experimental work uses
vesicle systems as biomimetic models, and a significant
effort has been made to identify natural and abiotic com-
pounds that promote or inhibit vesicle fusion. As a result of
this work, it is known empirically that cone-shaped amphi-
philes (relatively small head cross-section and large tail
cross-section) often promote membrane fusion, and also
increase the propensity of lamellar membranes to undergo
phase changes to non-lamellar structures such as inverse
hexagonal or cubic phases [15–19]. The most popular
mechanistic rationalization of this observation uses the
pore-stalk fusion model and proposes that cone-shaped
amphiphiles stabilize common intermediate membrane
structures with inversely curved surfaces [20,21]; however,
other explanations have been put forth (see below).
From an applied perspective, much attention has been
directed towards vesicles containing cationic lipids because
of the potential uses in transfection and drug delivery [22–
24]. Although vesicle-mediated delivery is a multistep
event, there is evidence that the rate-determining step for
certain cell types is endosomal escape, which can occur
either by a fusion or disruption process [25,26]. Thus, there
is a need for cationic lipids that can effectively promote the
fusion or disruption of bilayer membranes [27]. Recently,
Hafez et al. [28] reported that binary mixtures of cationic
and anionic polar lipids adopt inverted nonbilayer struc-
tures, and they used this effect to trigger vesicle fusion by
acidification. In addition, Smisterova´ et al. [29] found that
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the shape of a series of related cationic amphiphiles controls
the structure of cationic amphiphile/DOPE–DNA com-
plexes and the efficiency of gene delivery. These results
suggest that cationic, cone-shaped amphiphiles may pro-
mote vesicle fusion better than cylinder-shaped or inverse-
cone-shaped cationic amphiphiles [30–33]. This hypothesis
has lead us to compare the fusogenicity of cationic amphi-
philes with one, two or three hydrocarbon chains. In this
study, we evaluate the abilities of two groups of structurally
related amphiphiles (1–3 and 4–7) to induce membrane
fusion and find, for each group, that vesicles containing the
triple-chain versions are the most fusogenic. Although
triple-chain amphiphiles have been studied before [34–
41], they have never been previously directly attributed
with strong fusogenic activity.
2. Materials and methods
2.1. Materials
All polar lipids, including the fluorescent labeled ones
were obtained from Avanti Polar Lipids Inc. The fluorescent
markers 1-aminonaphthalene-3,6,8-trisulfonate (ANTS) and
N,NV-p-xylenebis(pyridinium bromide) (DPX) were ob-
tained from Molecular Probes and carboxyfluorescein from
Eastman Kodak Co. Dodecyltrimethylammonium bromide,
1, didodecyldimethylmmonium bromide, 2, and tridodecyl-
methylammonium chloride, 3, were purchased from Aldrich
Chemical Co. Compounds 4–7 were prepared using the
method of Thomas et al. [42]. First tris(2-aminoethyl)amine
(TREN) was acylated with the appropriate acid chloride(s).
The resulting triamides were then reduced their correspond-
ing amines with excess LiAlH4. Spectroscopic data: 4:
1H
NMR (500 MHz) y 2.74–2.57 (m, 18H), 1.50 (pentet, J = 7
Hz, 2H), 1.32–1.22 (m, 28H), 1.14 (br. t, J = 6.5 Hz, 6H),
0.87 (t, J = 7 Hz, 3H); 13C NMR (75 MHz, some signals in
aliphatic region overlap) y 54.2, 50.0, 47.7, 47.5, 44.1, 31.9,
30.1, 29.7, 29.64, 29.62, 29.59, 29.3, 27.4, 22.7, 15.2, 14.1.
FAB-HRMS (m/z) [M + 1] + calculated for C28H62N4
455.5057, found 455.5080. 5: 1H NMR (300 MHz) y
2.72–2.56 (m, 18H), 1.49 (pentet, J= 7 Hz, 4H), 1.34–
1.18 (m, 56H), 1.12 (br. t, J = 7 Hz, 3H), 0.87 (t, J = 7 Hz,
6H); 13C NMR (75 MHz, some signals in aliphatic region
overlap) y 54.2, 50.0, 47.7, 47.5, 44.0, 31.9, 30.1, 29.7,
29.6, 29.4, 27.4, 22.7, 15.1, 14.1. HRMS-FAB (m/z):
[M + H] + calculated for C44H94N4, 679.7562; found,
679.7564. 6: 1H NMR (300 MHz) y 2.64 (br. q, J = 5.4
Hz, 6H), 2.62–2.54 (m, 12H), 1.47 (br. t, J = 6 Hz, 6H),
1.26 (br. s, 66H), 0.88 (t, J = 6.6 Hz, 9H); 13C NMR (75
MHz) y 54.8, 50.3, 47.9, 31.9, 30.4, 29.7(21 C), 29.4, 27.5,
22.7, 14.1. HRMS-FAB (m/z): [M +H] + calculated for
C48H102N4, 735.8189; found, 735.8204. 7:
1H NMR (300
MHz) y 5.40–5.26 (m, 6H), 2.68–2.52 (m, 18H), 1.99 (br.
d, J = 5.4 Hz, 12H), 1.46 (br. t, J = 5.7 Hz, 6H), 1.28 (br. s,
54H), 0.87 (t, J = 5.4 Hz, 9H); 13C NMR (75 MHz, two
signals in aliphatic region overlap) y 129.9, 129.8, 54.5,
50.2, 47.8, 31.7, 30.3, 29.8, 29.7, 29.6, 29.5, 29.3, 28.9,
27.5, 27.2, 22.6, 14.0. HRMS-FAB (m/z): [M+H] + calcu-
lated for C54H109N4, 813.8659; found, 813.8676.
2.2. Unilamellar vesicle preparation
Measured aliquots of the appropriate phospholipids in
chloroform were placed in a 10 ml round-bottomed flask.
The chloroform was evaporated under reduced pressure on
a rotary evaporator and dried under vacuum for at least 1 h.
The dried lipids were hydrated with 100 mM NaCl/5 mM
TES buffer (pH 7.4) while vortexing using glass bead to
promote removal of the lipids from the flask walls. The
vesicle solution underwent a rapid freeze/thaw procedure
10 times unless they were to be used for a lipid mixing
assay or differential scanning calorimetry (DSC) where this
procedure was omitted. The vesicle solution was extruded,
at room temperature, 21 times through a polycarbonate
filter with 100 nm diameter pores using a hand-held Basic
LiposoFast extruder from Avestin, Inc. In the case of
contents mixing or leakage assays, the unencapsulated
marker compound was removed by overnight dialysis. 1H
and 13C NMR was used to determine vesicle composition
before and after dialysis. The vesicles were dried under
high vacuum and then redissolved in CDCl3. The ratio of
cationic amphiphile to phosphocholine was determined
from NMR peak integrations and did not change signifi-
cantly after dialysis.
Dynamic light scattering (Beckman Coulter N4 Plus)
showed a vesicle size of about 100F 20 nm before fusion.
After fusion, the size distribution was very broad and did
not provide useful information.
2.3. Lipid mixing assay
All fluorescence experiments were performed using
Perkin-Elmer LS50B fluorimeter. The probe dilution method
was used which measures the fluorescence resonance energy
transfer between an emitter, 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl
(NBD-PE), and a quencher 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(lissamine rhodamine B sulfonyl
(Rh-PE). Initially, both probes are in the same population
of vesicles. Upon fusion of the labeled vesicles with
unlabeled vesicles, the probes are diluted and quenching
by resonance energy transfer is decreased resulting in
increased fluorescence. The excitation wavelength for the
NBD-PE probe was set at 470 nm with emission measured
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at 530 nm using a 515 nm cutoff filter to reduce stray light
noise.
Two sets of lipid mixing experiments were conducted.
The first set involved mixing of oppositely charged
vesicles. Cationic unlabeled donor vesicles were added
to the anionic labeled acceptor vesicles in a 1:1 ratio in 3
ml of 100 mM NaCl/5 mM TES buffer at pH 7.4. The
second set of fusion experiments involved acid-triggered
self-fusion of vesicles composed of cationic amphiphile
and CHEMS. An aliquot of 0.5 M HCl was added to a
3.0 ml sample of vesicles in 100 mM NaCl/5 mM TES
buffer, pH 7.4. The ratio of labeled to unlabeled vesicles
was 1:5. At the end of each run, 2.5 mM octaethylene
glycol monododecyl ether was added to determine 100%
lipid mixing, and the final pH determined with an elec-
trode.
2.4. Contents mixing assay
Vesicles were prepared as above encapsulating either 25
mM ANTS/40 mM NaCl (anionic acceptor vesicles) or 90
mM DPX in 5 mM pH 7.4, TES buffer (cationic donor
vesicles). After vortexing, the lipid mixture was subjected to
10 rounds of freezing and thawing in an ethanol/dry ice bath
and 45 jC water bath, respectively. The dispersions were
then extruded as above and dialyzed overnight in 150 mM
NaCl using 15,000 MW cutoff dialysis tubing.
The excitation wavelength for ANTS was set at 354 nm
with emission measured at 530 nm using a 515-nm cutoff
filter to reduce stray light noise. Assays were performed by
mixing the donor/acceptor vesicle populations (50 AM final
phospholipid concentration) in 3 ml of 100 mM NaCl/5 mM
TES buffer (pH 7.4) and the fluorescence monitored over
time. Detergent (2.5 mM) was added to the samples after
300 s. The intensity of an initial sample and a reference
population of 12.5 mM ANTS/45 mM DPX/20 mM NaCl
vesicles were set to 100% and 0% contents mixing, respec-
tively.
2.5. Leakage assay
Acceptor vesicles were prepared as above, but encapsu-
lating 50 mM carboxyfluorescein/100 mM NaCl in 5 TES
buffer (pH 7.4). After vortexing, the lipid mixture was
subjected to 10 rounds of freezing and thawing in an
ethanol/dry ice bath and 45 jC water bath, respectively.
The lipids were then extruded as above and dialyzed over-
night in 150 mM NaCl using 15,000 MW cutoff dialysis
tubing. The excitation wavelength was set at 495 nm with
emission measured at 520 nm. The vesicles were added to 3
ml of 100 mM NaCl/5 mM TES buffer (pH 7.4). At 100 s
cationic donor vesicles, encapsulating100 mM NaCl/5 mM
TES buffer (pH 7.4) were added. Leakage were determined
from the initial fluorescence of the sample and after addition
of 2.5 mM octaethylene glycol monododecyl ether (0% and
100%), respectively.
2.6. Differential scanning calorimetry
Vesicles were prepared as above, using 99 mol% dipal-
mitoleoylphosphatidylethanolamine (DiPoPE) and 1% of
the compounds 1–4, or 7, to a final lipid concentration of
14.5 mM in 100 mM NaCl/5 mM TES buffer (pH 7.4). All
the samples and the buffers were degassed prior to use. A
VP-DSC (Microcal, Amherst, MA) high-sensitivity scan-
ning microcalorimeter was used with a cell volume of 0.5
ml. Continuous scans were recorded at a rate of 60 jC/h
from 10 to 60 jC.
3. Results and discussion
Unilamellar vesicle fusion was induced by mixing cati-
onic donor vesicles with an equal population of anionic
acceptor vesicles [43,44]. In the case of quaternary ammo-
nium cations, 1–3, the donor vesicles were composed of
5:3.5:1.5, egg phosphatidylethanolamine: egg phosphatidyl-
choline:X (eggPE:eggPC:X) where X is 1, 2, or 3, and the
Fig. 1. Lipid mixing. A population of unlabeled cationic donor vesicles (25
AM total lipid) was added at t = 100 s to an equal population of anionic
acceptor vesicles (containing 0.6% of the probes NBD-PE and Rh-PE) in
100 mM NaCl/5 mM TES buffer, T= 25 jC, pH 7.4. (A) Donor vesicles are
eggPE:eggPC:X (5:3.5:1.5) and acceptor vesicles are eggPE:eggPC:POPA
(5:3.5:1.5). (a) X = 1, (b) X = 2, (c) X = 3. (B) Donor vesicles are eggPE:egg
PC:X (5.5:3.5:1) and acceptor vesicles are eggPE:egg PC:POPA (5:3.5:1.5).
(a) X = 4, (b) X= 5, (c) X = 6, (d) X= 7.
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anionic acceptor vesicles were composed of 5:3.5:1.5,
eggPE:eggPC:POPA (POPA is 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphatidic acid). Vesicle fusion was monitored
at 25 jC and pH 7.4 by standard fluorescence assays for
intermembrane lipid mixing, aqueous contents mixing and
leakage [45]. Lipid mixing was monitored by the probe
dilution method which uses the fluorescently labeled phos-
pholipid, NBD-PE, and its resonance energy transfer
quencher, Rh-PE. One vesicle population containing 0.6%
of each of the probes, is added to another population that is
unlabeled. Lipid mixing is indicated by an increase in NBD-
PE fluorescence intensity due to diminished quenching as
the two probes are diluted. As shown in Fig. 1A, rapid lipid
mixing occurred when unlabeled cationic vesicles were
added to labeled anionic vesicles. The extent of lipid mixing
depended on the identity of the cationic amphiphile and
increased in the order, 1 < 2< 3. Control experiments with
the probes in both vesicle populations showed that the
fluorescence increases were not due to scattering effects.
More compelling evidence for vesicle fusion was gained
from contents mixing assays which started with two pop-
ulations of vesicles, anionic acceptors encapsulating the
fluorophore ANTS, and cationic donors containing the
quencher DPX. Only complete vesicle fusion and mixing
of aqueous contents can produce a decrease in fluorescence
intensity. The amounts of aqueous contents mixing after 2
min was 0%, 22% and 42% for 1, 2, and 3, respectively
(Fig. 2A). Leakage studies using acceptor vesicles contain-
ing carboxyfluoroscein revealed that fusion occurred with-
out any leakage of aqueous contents (Fig. 3A).
Essentially identical fusion experiments were conducted
with donor vesicles containing the amine amphiphiles 4–7
(Figs. 1B and 2B), and the same trend was observed, i.e., the
order of fusogenic activity is 4< 5 < 6 < 7. In addition to this
trend, we found that vesicles with unsaturated analogue 7
(containing three cis-hexadec-9-enyl chains) induced more
fusion and leakage (Figs. 2B and 3B) than vesicles with
saturated analogue 6 (containing three tetradecyl chains), a
structure/activity difference that has been noted before and
Fig. 2. Contents mixing. A population of cationic donor vesicles (25 AM
total lipid) containing DPX (90 mM) are added at t = 100 s to an equal
population of anionic acceptor eggPE:eggPC:POPA vesicles containing
ANTS (25 mM) in 100 mM NaCl/5 mM TES buffer, T= 25 jC, pH 7.4. At
t = 300 s, octaethylene glycol monododecyl ether is added to lyse the
vesicles. (A) Donor vesicles are eggPE:eggPC:X (5:3.5:1.5) and acceptor
vesicles are eggPE:eggPC:POPA (5:3.5:1.5), (a) X= 1, (b) X = 2, (c) X = 3.
(B) Donor vesicles are eggPE:eggPC:X (5.5:3.5:1) and acceptor vesicles are
eggPE:eggPC:POPA (5:3.5:1.5). (a) X = 4, (b) X = 5, (c) X = 6, (d) X = 7.
Fig. 3. Leakage. A population of cationic donor vesicles (25 AM total lipid)
was added at t = 100 s to an equal population of anionic acceptor vesicles
containing carboxyfluoroscein in 100mMNaCl/5mMTES buffer, T= 25 jC
pH 7.4. (a) X = 1, (b) X= 2, (c) X = 3. Octaethylene glycol monododecyl
ether, was added at 300 s. (A) Donor vesicles are eggPE:eggPC:X (5:3.5:1.5)
(25 AM) and acceptor vesicles are eggPE:eggPC:POPA (5:3.5:1.5), (a) X = 1,
(b) X = 2, (c) X = 3. (B) Donor vesicles are eggPE:eggPC:X (5.5:3.5:1) and
acceptor vesicles are eggPE:eggPC:POPA (14:3:3). (a) X = 4, (b) X = 5, (c)
X = 6, (d) X= 7.
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attributed to differences in amphiphile shape and chain
motion [46].
A fusogenicity order of 1 < 2 < 3 was also observed in
pH-dependent fusion experiments using vesicles composed
of CHEMS:X (85:15) where CHEMS is cholesteryl hemi-
succinate and X is either 1, 2 or 3. Recently, Hafez et al.
[28] showed that mixtures of CHEMS and cationic lipids
can form stable vesicles at neutral pH but these liposomes
undergo fusion as the pH is lowered. The critical point at
which fusion occurs is when the vesicle surface charge is
zero. Shown in Fig. 4 are acid-triggered lipid mixing
profiles for the CHEMS:X (85:15) vesicles. As the pH is
lowered, the initial fusion rates decrease although the final
extent of lipid mixing increases (leakage studies showed
that fusion occurred without any leakage of aqueous con-
tents, data not shown). Our trend of decreasing initial fusion
rate with increasing acidity is opposite of that observed by
Hafez et al., and most likely reflects an artifact due to
different acidification procedures. Hafez et al. triggered
fusion by injecting the vesicles into a buffered acid solution,
whereas we added an aliquot of acid to the vesicles. It is
likely that our method produced pH gradients resulting in an
initial fraction of the vesicles becoming highly cationic and
thus undergoing a slower rate of membrane fusion. In any
case, this artifact is tangential to our observation that the
extent of lipid mixing is 1 < 2 < 3. Overall, we find for both
amphiphilic structural groups, and for both methods of
vesicle fusion, that the order of fusogenic activity is sin-
gle-chain < double-chain < triple-chain.
The intuitive idea that the more branched, triple-chain
amphiphiles stabilize inversely curved membrane surfaces
compared to the double-chain or single-chain analogues
Fig. 4. Acid-triggered lipid mixing. An aliquot of 0.5 M HCl was added at
t = 100 s to a 1:5 mixture of labeled (containing 0.6% of the probes NBD-
PE and Rh-PE) and unlabeled vesicles composed of CHEMS:X (85:15)
(150 AM total lipid concentration) in 100 mM NaCl/5 mM TES buffer, pH
7.4. A, X = 1; B, X = 2; C, X = 3. The pH after HCl addition was (A)
pH= 6.2, (B) pH= 5, (C) pH= 4.
Fig. 5. Differential scanning calorimetry. (A) Lamellar to inverse hexagonal
phase transitions in pure DiPoPE (a) and mixtures of 99 mol% DiPoPE and
1 mol% of compounds 1 (b), 2 (c) and 3 (d). (B) mixtures of 99 mol%
DiPoPE and 1 mol% of compounds 4 (b) and 7 (c).
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[36,47], was confirmed by using DSC to measure the
effects of the cationic lipids on the lamellar– inverse
hexagonal phase transition temperature (TH) for DiPoPE.
Compounds that lower the TH for DiPoPE are considered to
stabilize inversely curved membrane surfaces [20]. As
shown in Fig. 5, the presence of 1 mol% of single-chain
1 raises TH from 44 to 49 jC, whereas 1% of triple-chain 3
lowers it to 32 jC. The triple-chain DSC results were
initially surprising since it was recently reported that
charged lipids raise the bilayer–nonbilayer phase transition
temperature for zwitterionic lipids [33]. It appears that the
inverse curvature stabilizing effect due to the cone-shape of
the triple-chain lipids overwhelms the destabilizing effect
of the charged head group. Similarly, the presence of 1% of
triple-chain analogue 7 lowers TH for DiPoPE to 32 jC,
whereas it is 40 jC in the presence of single-chain
analogue 4.
In addition to inverse membrane curvature stabilization,
other factors may contribute to the enhanced fusogenic
activity of the triple-chain amphiphiles, such as domain
formation, increased membrane packing defects, increased
chain motion, or increased surface dehydration [48]. While
domain formation is a possibility in the case of the egg-
PE:eggPC:X vesicles, it is much less likely in the case of
CHEMS:X vesicles because membrane mixing is favored
by electrostatic attraction of the oppositely charged mem-
brane components. In addition, domain formation of
CHEMS:X requires counter-ion immobilization which is
entropically costly [49]. A particularly intriguing mechanis-
tic proposal, which may be relevant in this case, is the
extended conformation hypothesis. To use the nomenclature
of Kinnunen and Holopainen [50], a cone-shaped, triple-
chain amphiphile is ‘‘sterically frustrated’’ in a bilayer
membrane which prefers to accommodate cylinder-shaped
lipids. During the fusion process, the triple-chain lipid can
momentarily relieve this steric frustration by adopting an
extended conformation that inserts one hydrocarbon chain
into the outer leaflet of an adhered, dehydrated bilayer.
Recent molecular dynamics calculations provide supporting
evidence for this type of physical picture [51].
In summary, two examples are described where cationic,
triple-chain amphiphiles promote vesicle fusion more than
structurally related double-chain or single-chain analogues.
The same trend is found for the transition of lamellar to
inverse hexagonal phase. The fusion enhancement is likely
due to differences in lipid dynamic shape and their effects
on membrane curvature (the cone-shaped triple-chain
amphiphiles best stabilize the inversely curved membrane
surfaces of the fusion intermediates). The structural sim-
plicity of these cationic amphiphiles, especially compounds
1–3 which are commercially available, makes them highly
amenable for detailed mechanistic study. From the perspec-
tive of drug delivery, our results suggest that vesicles
containing cationic, triple-chain amphiphiles (and cationic,
cone-shaped amphiphiles in general) may be effective as
fusogenic delivery capsules.
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